Back to search
FDAFDA · Food and drugs·Recall number D-1333-2015

Gemcitabine for Injection, USP, 2 g*/vial, Lyophilized powder in a Single-Use Vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103, Made in India, NDC 67457-463-02, UPC 3 67457 46302 5.

Published August 26, 2015 · Recall initiated: March 23, 2015

Summary

FDA records drug Class I recall D-1333-2015, published August 26, 2015 and initiated March 23, 2015. Recalling firm: Mylan Institutional LLC; Status: Terminated; Reported quantity: 2,455 vials; Lot: Lot #: 7801221, 7801222, Exp 03/16. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mylan Institutional LLC
Distributor
Nationwide and Puerto Rico
Lot
Lot #: 7801221, 7801222, Exp 03/16
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Gemcitabine for Injection, USP, 2 g*/vial, Lyophilized powder in a Single-Use Vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103, Made in India, NDC 67457-463-02, UPC 3 67457 46302 5. recalled?

Yes. FDA published recall D-1333-2015 on August 26, 2015. Reported hazard: Presence of Particulate Matter

What should I do if I have this product?

Voluntary: Firm initiated · Letter